GSK Pharma To Pump In Rs 1,000 Crore In Karnataka Plant


GlaxoSmithKline (GSK) Pharmaceuticals, a global healthcare company, is going to pour Rs 1,000 crore in its new pharma unit in Karnataka. The company is also looking at enhancing its global pipeline in segments such as vaccines and respiratory drugs in India.

The healthcare company is examining new possible products launches in the country from its global respiratory and vaccines pipeline and also reviewing complementary inorganic opportunities.

Almost 30% of the global pharmaceutical volumes sold by GSK is sold in the country.

The company is also upgrading its current Nashik facility. GSK India, in compliance with the GSK respiratory free strategy and the WHO requirement, has invested Rs 115 crore to construct a dedicated facility for the manufacturing of Eltroxin, which will be fully functional in 2018.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: